Mezzion Pharma Co.,Ltd. reported earnings results for the full year ended December 31, 2023. For the full year, the company reported sales was KRW 0.00023 million compared to KRW 0.00039 million a year ago. Net loss was KRW 12,728.38 million compared to KRW 36,297.83 million a year ago.

Basic loss per share from continuing operations was KRW 451 compared to KRW 1,358 a year ago. Diluted loss per share from continuing operations was KRW 451 compared to KRW 1,358 a year ago. Basic loss per share was KRW 451 compared to KRW 1,358 a year ago.